Related references
Note: Only part of the references are listed.TLR4 stimulation and corticosteroid interactively induce osteonecrosis of the femoral head in rat
Shunichiro Okazaki et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2016)
α-Melanocyte stimulating hormone attenuates dexamethasone-induced osteoblast damages through activating melanocortin receptor 4-SphK1 signaling
Shiguang Guo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Plasma Interleukin 33 Level in Patients With Osteonecrosis of Femoral Head: TABLE 1
Liwen Zheng et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Biomarkers and pharmaceutical strategies in steroid-induced osteonecrosis of the femoral head: A literature review
Xinyu Qi et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2015)
Immune response associated with Toll-like receptor 4 signaling pathway leads to steroid-induced femoral head osteonecrosis
Lei Tian et al.
BMC MUSCULOSKELETAL DISORDERS (2014)
Osteonecrosis of the Femoral Head: Evaluation and Treatment
Charalampos G. Zalavras et al.
JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS (2014)
Does vasculitis alone cause AVN? A review of literature
Rtika R. Abraham et al.
RHEUMATOLOGY INTERNATIONAL (2013)
Interleukin-33: A novel player in osteonecrosis of the femoral head?
Soraya Saidi et al.
JOINT BONE SPINE (2011)
Responsiveness of the VAS and McGill Pain Questionnaire in Measuring Changes in Musculoskeletal Pain
Amy Chaffee et al.
JOURNAL OF SPORT REHABILITATION (2011)
The Harris hip score: Do ceiling effects limit its usefulness in orthopedics?
Kim E. Wamper et al.
ACTA ORTHOPAEDICA (2010)
Low Plasma Adiponectin as a Potential Biomarker for Osteonecrosis of the Femoral Head
Bo Shuai et al.
JOURNAL OF RHEUMATOLOGY (2010)
Femoral head osteonecrosis can be caused by disruption of the systemic immune response via the toll-like receptor 4 signalling pathway
S. Okazaki et al.
RHEUMATOLOGY (2009)
The immunomodulating neuropeptide alpha-melanocyte-stimulating hormone (α-MSH) suppresses LPS-stimulated TLR4 with IRAK-M in macrophages
AW Taylor
JOURNAL OF NEUROIMMUNOLOGY (2005)
Neuropeptide Y, α-melanocyte-stimulating hormone, and morioamines in food intake regulation
EJB Ramos et al.
NUTRITION (2005)
Circulating melanin-concentrating hormone, agouti-related protein, and α-melanocyte-stimulating hormone levels in relation to body composition:: Alterations in response to food deprivation and recombinant human leptin administration
A Gavrila et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Plasma concentrations of α-MSH, AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation
N Hoggard et al.
CLINICAL ENDOCRINOLOGY (2004)
α-melanocyte-stimulating hormone is a novel regulator of bone
J Cornish et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2003)
alpha-melanocyte stimulating hormone prevents lipopolysaccharide-induced vasculitis by down-regulating endothelial cell adhesion molecule expression
TE Scholzen et al.
ENDOCRINOLOGY (2003)
Mouse melanocortin-4 receptor gene 5′-flanking region imparts cell specific expression in vitro
LM Dumont et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2001)
Elevated plasma levels of α-melanocyte stimulating hormone (α-MSH) are correlated with insulin resistance in obese men
A Katsuki et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency
IS Farooqi et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
